Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
BIOSANTE PHARM Add to My Watchlist (NSDQ: BPAX) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     BioSante 1.50 +0.06 (+4.17%) 171,434
111 Barclay Boulevard
Suite 280
Lincolnshire, IL 60069 US
(847) 478-0500
(847) 478-9152 fax
www.biosantepharma.com
CEO Stephen M. Simes
Auditor DELOITTE & TOUCHE LLP
Exchange Traded NQ
ISIN Number US09065V2034
CIK Number 1023024
NAICS Code 325414
Business Summary
A specialty pharmaceutical company, focused on developing products for female sexual health, menopause, contraception and male hypogonadism.
Number of Employees 23
Share Fundamentals
Market Cap 79.89M
Shares Outstanding 53.26M
Float 24.18M
Short Interest 2.69M
Financial Strength
Revenue (TTM) $3,875,212
Earnings (TTM) -$16,422,084
Quick Ratio 1.6:1
Current Ratio 2.1:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs